Similar articles

• Revascularization for renal-artery stenosis.

  Wilentz JR. Wilentz JR. N Engl J Med. 2010 Feb 25;362(8):762; author reply 763-4. N Engl J Med. 2010. PMID: 20191668 No abstract available.
• Revascularization for renal-artery stenosis.

  Staub D, Uthoff H, Jaeger KA. Staub D, et al. N Engl J Med. 2010 Feb 25;362(8):762; author reply 763-4. doi: 10.1056/NEJMc0912419. N Engl J Med. 2010. PMID: 20181982 No abstract available.
• [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].

  Alhadad A, Sterner G, Herlitz H. Alhadad A, et al. Lakartidningen. 2009 Oct 28-Nov 3;106(44):2836-8, 2840. Lakartidningen. 2009. PMID: 19967962 Review. Swedish. No abstract available.
• Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials.

  Kumbhani DJ, Bavry AA, Harvey JE, de Souza R, Scarpioni R, Bhatt DL, Kapadia SR. Kumbhani DJ, et al. Am Heart J. 2011 Mar;161(3):622-630.e1. doi: 10.1016/j.ahj.2010.12.006. Am Heart J. 2011. PMID: 21392620
• [Ischemic renal disease: revascularization or conservative treatment?].

  Rodríguez Jornet A, Ibeas J, Ribera L, Real J, Perendreu J, Falcó J, Vallespín J, Allegué N, Giménez Gaibar A, García García M. Rodríguez Jornet A, et al. Nefrologia. 2005;25(3):258-68. Nefrologia. 2005. PMID: 16053007 Review. Spanish.